Professor Rachel Grossman is the director Rambam’s Brain Tumor Center and the deputy director of the Department of Neurosurgery.
After completing her medical studies at the Faculty of Medicine of Tel Aviv University, she completed a post-doctorate in the field of neuroscience research in the Lawrence Berkeley National Laboratory. She subsequently completed a neurosurgical residency at Sheba Medical Center in Israel, and then joined the Surgical Neurology Department at Johns Hopkins Hospital, MD, USA, where she led a variety of research projects, including innovative approaches for brain tumor therapy.
After returning to Israel, Professor Grossman joined the faculty of Tel Aviv University in 2011 and served as the deputy director of the Department of Neurosurgery in Tel Aviv Medical Center and launched an active clinical and academic career focused on brain tumor therapy, pituitary surgery, extended endoscopic skull base approaches, and technology development projects with various international medical device companies.
Professor Grossman recently joined the neurosurgery department at Rambam Health Care Campus where she established the hospital’s Brain Tumor Center. The center is comprised of a multidisciplinary team who work together to provide the latest safe, effective, and cutting edge treatments via surgical innovations and a patient-centered research program for a variety of brain tumors.
A member of the Tumor Section of the European Association of Neurosurgical Societies (EANS) and the World Federation of Neurosurgical Societies (WFNS), she has served on executive steering committees and served as the lead principal investigator (PI) for several pharmaceutical companies conducting multicenter international clinical studies. Professor Grossman is a scientific advisor for biotechnology companies, a member of several editorial boards, and a reviewer for leading scientific journals in her areas of expertise.
Professor Grossman's main clinical interests include surgery for complex brain tumors including awake craniotomies with intra-operative cortical mapping and white matter tracking when tumors are within or near functional brain regions; endoscopic surgery for pituitary and skull base tumors; and complex operations for benign tumors of the brain. Her main research areas include novel therapeutics for malignant brain tumors, including innovative immunotherapeutic approaches, combination therapies, and advanced translational imaging technologies in surgical planning.
The author of more than 80 original per-reviewed articles published in the international scientific literature, Professor Grossman has also written book chapters and received several competitive research grants. A popular invited lecturer at international conferences, Professor Grossman has initiated and led a large number of groundbreaking clinical studies in the field of brain tumors, laboratory studies, and research collaborations with leading centers in Israel, Europe, and the United States.
